1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Nutritional Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Nutritional Supplements Market, by Form Type
8.1.1. Powder
8.1.1.1. Market Revenue and Forecast
8.1.2. Tablets
8.1.2.1. Market Revenue and Forecast
8.1.3. Capsules
8.1.3.1. Market Revenue and Forecast
8.1.4. Liquid
8.1.4.1. Market Revenue and Forecast
8.1.5. Soft gels
8.1.5.1. Market Revenue and Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Forecast
9.1. Nutritional Supplements Market, by Product
9.1.1. Sports Nutrition
9.1.1.1. Market Revenue and Forecast
9.1.2. Dietary Supplements
9.1.2.1. Market Revenue and Forecast
9.1.3. Fat Burner
9.1.3.1. Market Revenue and Forecast
9.1.4. Functional Food
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Nutritional Supplements Market, by Age Group
10.1.1. Kids
10.1.1.1. Market Revenue and Forecast
10.1.2. Adults
10.1.2.1. Market Revenue and Forecast
10.1.3. Geriatric
10.1.3.1. Market Revenue and Forecast
11.1. Nutritional Supplements Market, by Distribution Channel
11.1.1. Supermarkets/Hypermarkets
11.1.1.1. Market Revenue and Forecast
11.1.2. Specialty Stores
11.1.2.1. Market Revenue and Forecast
11.1.3. Pharmacies
11.1.3.1. Market Revenue and Forecast
11.1.4. E-commerce
11.1.4.1. Market Revenue and Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Form
12.1.2. Market Revenue and Forecast, by Product
12.1.3. Market Revenue and Forecast, by Age Group
12.1.4. Market Revenue and Forecast, by Distribution Channel
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Form
12.1.5.2. Market Revenue and Forecast, by Product
12.1.5.3. Market Revenue and Forecast, by Age Group
12.1.5.4. Market Revenue and Forecast, by Distribution Channel
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Form
12.1.6.2. Market Revenue and Forecast, by Product
12.1.6.3. Market Revenue and Forecast, by Age Group
12.1.6.4. Market Revenue and Forecast, by Distribution Channel
12.2. Europe
12.2.1. Market Revenue and Forecast, by Form
12.2.2. Market Revenue and Forecast, by Product
12.2.3. Market Revenue and Forecast, by Age Group
12.2.4. Market Revenue and Forecast, by Distribution Channel
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Form
12.2.5.2. Market Revenue and Forecast, by Product
12.2.5.3. Market Revenue and Forecast, by Age Group
12.2.5.4. Market Revenue and Forecast, by Distribution Channel
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Form
12.2.6.2. Market Revenue and Forecast, by Product
12.2.6.3. Market Revenue and Forecast, by Age Group
12.2.6.4. Market Revenue and Forecast, by Distribution Channel
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Form
12.2.7.2. Market Revenue and Forecast, by Product
12.2.7.3. Market Revenue and Forecast, by Age Group
12.2.7.4. Market Revenue and Forecast, by Distribution Channel
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Form
12.2.8.2. Market Revenue and Forecast, by Product
12.2.8.3. Market Revenue and Forecast, by Age Group
12.2.8.4. Market Revenue and Forecast, by Distribution Channel
12.3. APAC
12.3.1. Market Revenue and Forecast, by Form
12.3.2. Market Revenue and Forecast, by Product
12.3.3. Market Revenue and Forecast, by Age Group
12.3.4. Market Revenue and Forecast, by Distribution Channel
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Form
12.3.5.2. Market Revenue and Forecast, by Product
12.3.5.3. Market Revenue and Forecast, by Age Group
12.3.5.4. Market Revenue and Forecast, by Distribution Channel
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Form
12.3.6.2. Market Revenue and Forecast, by Product
12.3.6.3. Market Revenue and Forecast, by Age Group
12.3.6.4. Market Revenue and Forecast, by Distribution Channel
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Form
12.3.7.2. Market Revenue and Forecast, by Product
12.3.7.3. Market Revenue and Forecast, by Age Group
12.3.7.4. Market Revenue and Forecast, by Distribution Channel
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Form
12.3.8.2. Market Revenue and Forecast, by Product
12.3.8.3. Market Revenue and Forecast, by Age Group
12.3.8.4. Market Revenue and Forecast, by Distribution Channel
12.4. MEA
12.4.1. Market Revenue and Forecast, by Form
12.4.2. Market Revenue and Forecast, by Product
12.4.3. Market Revenue and Forecast, by Age Group
12.4.4. Market Revenue and Forecast, by Distribution Channel
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Form
12.4.5.2. Market Revenue and Forecast, by Product
12.4.5.3. Market Revenue and Forecast, by Age Group
12.4.5.4. Market Revenue and Forecast, by Distribution Channel
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Form
12.4.6.2. Market Revenue and Forecast, by Product
12.4.6.3. Market Revenue and Forecast, by Age Group
12.4.6.4. Market Revenue and Forecast, by Distribution Channel
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Form
12.4.7.2. Market Revenue and Forecast, by Product
12.4.7.3. Market Revenue and Forecast, by Age Group
12.4.7.4. Market Revenue and Forecast, by Distribution Channel
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Form
12.4.8.2. Market Revenue and Forecast, by Product
12.4.8.3. Market Revenue and Forecast, by Age Group
12.4.8.4. Market Revenue and Forecast, by Distribution Channel
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Form
12.5.2. Market Revenue and Forecast, by Product
12.5.3. Market Revenue and Forecast, by Age Group
12.5.4. Market Revenue and Forecast, by Distribution Channel
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Form
12.5.5.2. Market Revenue and Forecast, by Product
12.5.5.3. Market Revenue and Forecast, by Age Group
12.5.5.4. Market Revenue and Forecast, by Distribution Channel
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Form
12.5.6.2. Market Revenue and Forecast, by Product
12.5.6.3. Market Revenue and Forecast, by Age Group
12.5.6.4. Market Revenue and Forecast, by Distribution Channel
13.1. Abbott Nutrition
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Amway
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nestle
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Glanbia Plc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Herbalife International of America
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Archer Daniels Midland
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GlaxoSmithKline
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Nature’s Bounty Co.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Arkopharma Laboratories Pharmaceutiques
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. DuPont
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. American Health, Inc.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. Pfizer, Inc.
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
13.13. Stepan Company
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance
13.13.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
